Today: 1 May 2026
Energy stocks jump to start 2026 as Exxon, Chevron rise; OPEC+ and Venezuela in focus
3 January 2026
2 mins read

Energy stocks jump to start 2026 as Exxon, Chevron rise; OPEC+ and Venezuela in focus

NEW YORK, January 3, 2026, 13:36 ET — Market closed

  • U.S. energy shares closed higher on Friday, led by oilfield services and exploration names
  • Crude ended slightly lower, with traders weighing oversupply concerns against geopolitical risk
  • Markets next look to an OPEC+ output meeting and fast-moving headlines out of Venezuela

U.S. energy stocks kicked off 2026 with broad gains on Friday, with oilfield services and exploration-and-production names outperforming even as crude futures finished slightly lower. Oil Services ETF OIH rose 3.9% and the SPDR S&P Oil & Gas Exploration & Production ETF XOP gained 2.1%.

Among large caps, Exxon Mobil ended up 1.9% at $122.65 and Chevron gained 2.3% to $155.90, while oilfield services provider SLB jumped 4.8% to $40.20.

The outperformance matters now because investors began the year rotating into value-linked sectors and “real economy” beneficiaries, even as markets reset expectations for growth and rates. In the broader market, trading was light and sector leadership shifted away from megacap technology, a Reuters report showed. Reuters

At the same time, oil is coming off a steep 2025 slide, leaving energy shares sensitive to any sign of tighter supply or fresh geopolitical disruption. Crude’s push-and-pull between near-term headlines and longer-term oversupply forecasts is setting the tone for the sector early in 2026.

On Friday, U.S. West Texas Intermediate (WTI) — the main U.S. crude benchmark — settled at $57.32 a barrel, down 0.17%, while Brent — the global benchmark — settled at $60.75, down 0.16%, according to Reuters.

Investors are also watching OPEC+ — the Organization of the Petroleum Exporting Countries and allies including Russia — with a virtual meeting scheduled for Sunday, January 4. Traders widely expect the group to keep output increases on hold in the first quarter, Reuters reported.

“2026 will be an important year on assessing OPEC+ decisions for balancing supply,” Sparta Commodities analyst June Goh said. New Orleans CityBusiness

Other analysts have pointed to limited upside in crude without a clearer shift in fundamentals. DBS energy analyst Suvro Sarkar said Brent could be largely range-bound around $60–$65 a barrel, while Phillip Nova analyst Priyanka Sachdeva flagged the tension between geopolitical risk and oversupply signals.

Geopolitics added another variable over the weekend after President Donald Trump said U.S. oil companies were prepared to enter Venezuela and invest to restore production following the removal of President Nicolás Maduro, according to Reuters. Chevron said it was focused on employee safety and asset integrity and that it was operating in compliance with laws and regulations.

Even so, the near-term impact on oil flows remains uncertain. Venezuela’s state-run PDVSA reported no damage to production and refining infrastructure after the U.S. strike, and two sources familiar with operations said facilities were running normally, Reuters reported.

On the supply outlook, the U.S. Energy Information Administration said it forecasts U.S. crude oil production will average about 13.5 million barrels per day in 2026, roughly 100,000 barrels per day less than in 2025. The agency also forecast WTI would average $51 a barrel in 2026, with Brent near $55, as inventories rise.

In the week ahead, investors will be watching for any shift in OPEC+ messaging on output, and whether Venezuela-related headlines translate into measurable changes in exports or shipping behavior. Macro catalysts also loom, with markets looking for a return to a fuller U.S. data calendar after disruption tied to the recent government shutdown, Reuters reported.

Before the next session, traders will also focus on energy’s earnings runway, especially guidance on capital spending, buybacks and production discipline. Exxon’s investor site lists a 4Q25 “earnings considerations” 8-K — an SEC filing used to disclose material information — expected after market hours on Wednesday, January 7. Exxon Mobil Corporation

Oilfield services could set the tone earlier: SLB has scheduled its fourth-quarter earnings conference call for January 23, while ConocoPhillips’ investor calendar lists its fourth-quarter earnings conference call for February 5.

Stock Market Today

  • Goldman Sachs Lowers Pfizer Price Target Ahead of Q1 Earnings
    May 1, 2026, 5:46 PM EDT. Goldman Sachs analyst Asad Haider has maintained a hold rating on Pfizer and lowered the stock's price target to $26. This cautious stance comes ahead of Pfizer's first-quarter 2026 earnings report, with the company facing headwinds from declining Covid-related sales and patent expirations. Pfizer projects 2026 revenues of $59.5 billion to $62.5 billion, including an expected $3 billion revenue hit due to Covid product declines and loss of exclusivity on key drugs. Investors await signs of revenue stabilization, cost controls, and growth from Pfizer's drug pipeline. Despite challenges, Pfizer expects about 4% operational revenue growth excluding Covid and generic competition. Recent settlements over Vyndamax, a heart failure drug, offer some relief as Pfizer navigates a critical transition period for its business.

Latest article

Woodside’s $17.5 Billion Louisiana LNG Bet Hits a Buyer Snag

Woodside’s $17.5 Billion Louisiana LNG Bet Hits a Buyer Snag

1 May 2026
Woodside is struggling to secure buyers for LNG from its planned Louisiana export plant, with liquefaction fees above U.S. market rates stalling talks, sources told Reuters. The company has signed only one long-term sales deal so far. Shares closed at A$33.12 in Sydney, down 1.28%. The Louisiana LNG project was 24% complete at the end of March and targets first cargo in 2029.
Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

Why Zscaler Stock Jumped Today Despite a Wall Street Target Cut

1 May 2026
Zscaler shares climbed 7% to $139.81 Friday despite a price-target cut by Citizens JMP to $210. The move followed a sector rally after Atlassian raised its forecast. Zscaler reported 26% revenue growth last quarter and expanded AI security features in its GovCloud product. Customers remain cautious on large deals, with longer approval times noted.
Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines
Previous Story

Healthcare Stocks Today: XLV edges up as drugmakers raise U.S. list prices on 350 medicines

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom
Next Story

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom

Go toTop